ANRO
Price
$3.08
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
83.38M
23 days until earnings call
KLRS
Price
$2.76
Change
-$0.08 (-2.82%)
Updated
Jul 25 closing price
Capitalization
51.62M
Interact to see
Advertisement

ANRO vs KLRS

Header iconANRO vs KLRS Comparison
Open Charts ANRO vs KLRSBanner chart's image
Alto Neuroscience
Price$3.08
Change-$0.00 (-0.00%)
Volume$117.45K
Capitalization83.38M
Kalaris Therapeutics
Price$2.76
Change-$0.08 (-2.82%)
Volume$41.29K
Capitalization51.62M
ANRO vs KLRS Comparison Chart in %
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. KLRS commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a StrongBuy and KLRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ANRO: $3.08 vs. KLRS: $2.76)
Brand notoriety: ANRO and KLRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 43% vs. KLRS: 82%
Market capitalization -- ANRO: $83.38M vs. KLRS: $51.62M
ANRO [@Biotechnology] is valued at $83.38M. KLRS’s [@Biotechnology] market capitalization is $51.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileKLRS’s FA Score has 1 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • KLRS’s FA Score: 1 green, 4 red.
According to our system of comparison, KLRS is a better buy in the long-term than ANRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 5 TA indicator(s) are bullish while KLRS’s TA Score has 4 bullish TA indicator(s).

  • ANRO’s TA Score: 5 bullish, 5 bearish.
  • KLRS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANRO is a better buy in the short-term than KLRS.

Price Growth

ANRO (@Biotechnology) experienced а +10.79% price change this week, while KLRS (@Biotechnology) price change was +15.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

ANRO is expected to report earnings on Aug 19, 2025.

KLRS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANRO($83.4M) has a higher market cap than KLRS($51.6M). KLRS YTD gains are higher at: 557.143 vs. ANRO (-27.187). ANRO has more cash in the bank: 161M vs. KLRS (101M).
ANROKLRSANRO / KLRS
Capitalization83.4M51.6M162%
EBITDA-60.98MN/A-
Gain YTD-27.187557.143-5%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash161M101M159%
Total Debt26.4MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ANROKLRS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHFFF0.47N/A
N/A
China Everbright Environment Group Ltd.
JDLGF1.40N/A
N/A
JD LOGISTICS INC.
FNMAH10.81-0.33
-3.00%
Fannie Mae
ECTM0.60-0.05
-8.16%
ECA Marcellus Trust I
IPGGF0.09-0.04
-29.17%
IMPERIUM TECHNOLOGY GROUP LTD.

ANRO and

Correlation & Price change

A.I.dvisor tells us that ANRO and NUVL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANRO and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
N/A
NUVL - ANRO
30%
Poorly correlated
-0.82%
XTLB - ANRO
27%
Poorly correlated
N/A
NTLA - ANRO
26%
Poorly correlated
+6.38%
RLAY - ANRO
25%
Poorly correlated
+1.63%
BEAM - ANRO
25%
Poorly correlated
+3.68%
More

KLRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLRS has been loosely correlated with PTHS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KLRS jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLRS
1D Price
Change %
KLRS100%
-2.82%
PTHS - KLRS
39%
Loosely correlated
-0.05%
SPRO - KLRS
21%
Poorly correlated
-1.06%
VRTX - KLRS
9%
Poorly correlated
N/A
JBIO - KLRS
6%
Poorly correlated
-0.60%
ANRO - KLRS
5%
Poorly correlated
N/A
More